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Abstract
Background: Striatin, a putative protein phosphatase 2A (PP2A) B-type regulatory subunit, is a multi-domain
scaffolding protein that has recently been linked to several diseases including cerebral cavernous malformation
(CCM), which causes symptoms ranging from headaches to stroke. Striatin association with the PP2A A/C (structural
subunit/catalytic subunit) heterodimer alters PP2A substrate specificity, but targets and roles of striatin-associated
PP2A are not known. In addition to binding the PP2A A/C heterodimer to form a PP2A holoenzyme, striatin
associates with cerebral cavernous malformation 3 (CCM3) protein, the mammalian Mps one binder (MOB)
homolog, Mob3/phocein, the mammalian sterile 20-like (Mst) kinases, Mst3, Mst4 and STK25, and several other
proteins to form a large signaling complex. Little is known about the molecular architecture of the striatin complex
and the regulation of these sterile 20-like kinases.
Results: To help define the molecular organization of striatin complexes and to determine whether Mst3 might be
negatively regulated by striatin-associated PP2A, a structure-function analysis of striatin was performed. Two distinct
regions of striatin are capable of stably binding directly or indirectly to Mob3–one N-terminal, including the coiled-
coil domain, and another more C-terminal, including the WD-repeat domain. In addition, striatin residues 191-344
contain determinants necessary for efficient association of Mst3, Mst4, and CCM3. PP2A associates with the coiled-
coil domain of striatin, but unlike Mob3 and Mst3, its binding appears to require striatin oligomerization. Deletion
of the caveolin-binding domain on striatin abolishes striatin family oligomerization and PP2A binding. Point
mutations in striatin that disrupt PP2A association cause hyperphosphorylation and activation of striatin-associated
Mst3.
Conclusions: Striatin orchestrates the regulation of Mst3 by PP2A. It binds Mst3 likely as a dimer with CCM3 via
residues lying between striatin’s calmodulin-binding and WD-domains and recruits the PP2A A/C heterodimer to its
coiled-coil/oligomerization domain. Residues outside the previously reported coiled-coil domain of striatin are
necessary for its oligomerization. Striatin-associated PP2A is critical for Mst3 dephosphorylation and inactivation.
Upon inhibition of PP2A, Mst3 activation appears to involve autophosphorylation of multiple activation loop
phosphorylation sites. Mob3 can associate with striatin sequences C-terminal to the Mst3 binding site but also with
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Protein phosphatase 2A (PP2A) is a multifunctional ser-
ine/threonine phosphatase found in all eukaryotes that
regulates a host of cellular processes [1,2]. It is com-
posed of a core heterodimer consisting of a structural A
subunit and a catalytic C subunit [1], which further
complexes with regulatory B-type subunits to form het-
erotrimeric PP2A holoenzymes. The B-type subunits
direct PP2A to specific signaling complexes and subcel-
lular locations [1] and regulate the activity of the C sub-
unit towards different substrates (for examples, see
[3-8]). While there are only two isoforms of the A and
C subunits (a, b), there are several families of B-type
subunits (B55/B, B56/B’,a n dB ’’). In addition to these
three families of B-type subunits, the striatin family of
scaffolding proteins (striatin, S/G2 nuclear autoantigen
(SG2NA), and zinedin) represents a possible fourth
family of PP2A B-type subunits in that they bind PP2A
A/C heterodimers in the absence of other B-type subu-
nits [8,9] and alter the activity of the bound PP2A A/C
heterodimer [8].
Striatin family members serve as molecular scaffolds
that organize large signaling complexes. Striatin,
SG2NA, and zinedin contain multiple protein-binding
domains: a caveolin-binding domain [10], a coiled-coil
domain [11], a Ca
2+-calmodulin-binding domain [12],
and a WD-repeat domain [13] (Figure 1A). Consistent
with the presence of these domains, striatin family
members have been reported to associate with calmodu-
l i ni naC a
2+-dependent manner [8,11,13] and with
caveolin-1 [10]. In addition, striatin family members oli-
gomerize with each other [14] and the coiled-coil
domain has been shown to mediate this interaction [15].
Other proteins found in complexes with striatin family
members include, but are not limited to, Mob3/phocein
(called Mob3 herein) [14,16], which is involved in vesi-
cular trafficking [16-18]; Mst3, Mst4, and STK25 [9],
members of the Germinal Center Kinase-III (GCK-III)
subfamily of sterile 20-like kinases recently implicated in
control of cell migration, cell cycle, Golgi assembly, and
cell polarity [19-22]; cerebral cavernous malformation 3
(CCM3) protein [9], which is required for stabilization
of the GCK-III kinases and thus for their function [21];
and striatin-interacting proteins (STRIP) 1 and 2 [9]. In
addition, striatin family complexes containing PP2A,
Mob3, GCK-III kinases, CCM3, and STRIP 1 and 2 can
also associate mutually exclusively with additional com-
ponents [9]. Finally, striatin has been found to bind Gai
and estrogen receptor a, facilitating rapid non-genomic
signaling of estrogen receptor a [23].
Several lines of evidence suggest that a common func-
tion of striatin family complexes is their involvement in
endocytosis and vesicular trafficking. Striatin, SG2NA
and the common associated protein Mob3 are localized
to the Golgi, cytoplasm, and plasma membrane [14,16]
and the Golgi localizations of SG2NA and Mob3 are
rapidly altered by exposure of cells to brefeldin A, an
inhibitor of Arfs, small G proteins known to regulate
vesicular trafficking [16]. In addition, striatin, SG2NA,
and Mob3 all associate with proteins implicated in
endocytosis and vesicular trafficking [17,24]. Finally,
both CCM3 and the Drosophila Mob3/phocein homo-
log, DMob4, have been directly implicated in endocyto-
sis and/or vesicular trafficking [18,25].
Striatin complexes have been linked to several clinical
conditions. The CCM3 protein found in striatin com-
plexes is one of three gene products mutated in cerebral
cavernous malformation, a common type of angioma
[9,26-28]. Moreover, a small deletion in the 3’ untrans-
lated region of striatin that leads to lower levels of stria-
tin mRNA was recently implicated in a canine model of
arrhythmogenic right ventricular cardiomyopathy [29].
Finally, the striatin gene was also found in one of
twenty-two loci containing common variants associated
with QRS interval length and cardiac ventricular
Figure 1 Schematic of the structures of human wild-type and
mutant striatin proteins. (A) Schematic of wild-type striatin, drawn
to scale, showing the locations of its previously published protein-
interaction domains. White boxes represent regions of unknown
function. (B) Stick diagrams of wild-type and mutant striatins used
in this study. Point mutations are denoted by X’s, and deletions
are shown as peaks in the stick diagrams or absence of a line.
Positions of mutants are noted relative to wild-type striatin
domains in panel A.
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Page 2 of 18conduction [30]. Thus, the study of striatin family com-
plexes is of great interest because of their potential roles
in vesicular trafficking, Golgi assembly, cell polarity, cell
migration, cell cycle, signaling, and disease.
Despite the identification of a large number of compo-
nents of striatin family complexes, little is known about
the architecture of these complexes and their regulation.
Defining the molecular organization of striatin family
complexes is critical to understanding how they function.
Equally important is the elucidation of the targets, roles,
and regulation of the phosphatase and kinase enzymes in
these complexes. Striatin association with the PP2A A/C
heterodimer alters PP2A’s substrate specificity [8], but
the targets and role(s) of striatin-associated PP2A are not
known. Treatment of cells with okadaic acid at concen-
trations known to inhibit PP2A induces hyperphosphory-
lation of striatin, SG2NA, Mob3, and other unidentified
striatin family binding partners, including proteins that
migrate at the size and isoelectric point of Mst3 and
Mst4 [14]. Thus, striatin-associated PP2A may regulate
the function of striatin-family complexes by modulating
the phosphorylation state of striatin and its associated
proteins, including the Mst3 and Mst4 kinases. However,
this hypothesis has not been directly tested.
To help define the molecular organization of striatin
complexes and to determine whether Mst3 might be
regulated by striatin-associated PP2A, we performed a
structure-function analysis of striatin, defining domains
of striatin important for the binding of a number of
striatin binding partners and determining the effect of
PP2A-deficient striatin mutants on the activation state
of Mst3. To gain insight into the mechanism of Mst3
activation by autophosphorylation, we also performed a
mutational analysis of Mst3 activation loop phosphoryla-
tion sites. Our results greatly enhance our understand-
ing of the architecture of striatin family complexes,
uncover unique binding requirements for PP2A, and
provide new insight into the oligomerization of striatin
family members and into the mechanism of activation
of Mst3 by autophosphorylation. Overall, they support a
model in which striatin orchestrates the regulation of
Mst3 by PP2A to regulate Mst3 function in the cell.
Results
Generation of striatin mutants for structure-function
analysis of striatin complexes
To facilitate dissection of the molecular organization of
striatin complexes, we generated a set of deletion mutants
and a complementary set of point mutants of striatin for
use in our experiments. Because all cells tested to date
contain endogenous striatin, all striatin mutants were con-
structed with an N-terminal Hemagglutinin (HA)-epitope
tag to allow specific immunoprecipitation and detection of
the exogenously expressed wild-type and mutant striatins.
Figure 1A shows the known domain organization of stria-
tin while Figure 1B shows a schematic of the different
striatin mutants used in this study on the same scale as
Figure 1A.
The WD-repeats of striatin are not required for PP2A
binding but contribute to Mob3 association
The A and C subunits of PP2A are known to bind striatin
[8] but the region of striatin that binds to PP2A is
unknown. As a first approach to identifying striatin
sequences important for PP2A association, we compared
the relative ability of HA-epitope tagged wild-type stria-
tin and two HA-tagged striatin C-terminal deletion
mutants, K270Stop and F457Stop (Figure 1), to bind
PP2A in vivo. Both bind PP2A (Figure 2A). Quantitation
of the ratio of PP2A bound to striatin shows that loss of
seven of eight of striatin’s WD-repeats (F457Stop) has no
effect on PP2A association while loss of all eight WD-
repeats plus the central region of striatin (K270Stop) has
only a small effect on PP2A binding that was not statisti-
cally significant (Figure 2B). These data indicate that resi-
dues 270-780 of human striatin are largely dispensable
for PP2A association and that the first 269 amino acids
of striatin contain the primary PP2A binding domain.
To determine the importance of C-terminal striatin
sequences for Mob3/striatin complex formation, the same
immunoprecipitates were probed for Mob3. Mob3, like
PP2A, also binds to both of the C-terminal deletion
mutants (Figure 2A). Thus, amino acids 1-269 in striatin
also contain a domain that binds Mob3, either directly or
indirectly. However, quantitation of results from multiple
experiments shows that Mob3 binds at reduced levels to
both of the C-terminal mutants (Figure 2B). Loss of seven
WD-repeats (F457Stop) or all eight WD-repeats plus the
central region of striatin (K270Stop) results in a 29% or
45% reduction in Mob3 binding, respectively. These results
demonstrate that the WD-repeats are important for effi-
cient association of Mob3 and that residues between 270
and 457 may also contribute. Thus, striatin residues 1-269
contain binding sites for both Mob3 and PP2A.
Both N- and C-terminal sequences of striatin associate
with Mob3 but only N-terminal striatin sequences
associate stably with PP2A
The reduced binding of Mob3 to both of the striatin C-
terminal deletion mutants suggested that striatin
sequences beyond residue 269 might bind Mob3. To
test for this possibility, immunoprecipitates of Δ(3-309)
striatin, an N-terminal deletion mutant of striatin (Fig-
ure 1), were probed for the presence of Mob3. The Δ(3-
309) striatin mutant bound Mob3 at approximately 40%
the level of wild-type striatin (Figure 2C-D). Thus, there
are at least two distinct domains within striatin (aa1-269
and aa310-780) capable of interacting directly or
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hand, did not bind to Δ(3-309) striatin (Figure 2C-D),
demonstrating that PP2A associates stably only with
residues located in the N-terminal region of striatin.
The coiled-coil and caveolin-binding domains of striatin,
but not the calmodulin-binding domain of striatin, are
necessary for oligomerization and for PP2A binding
To further localize the PP2A-binding domain within the
N-terminal 269 amino acids of striatin, HA-tagged
striatin mutants lacking previously identified N-terminal
protein-interaction domains (caveolin-binding, coiled-
coil, or calmodulin-binding) were created (Figure 1).
Co-immunoprecipitation was utilized to test the abilities
of these mutants to bind PP2A C subunit (Figure 3).
The coiled-coil domain of striatin is required for binding
PP2A, since a coiled-coil deletion mutant, Δ(70-116), is
unable to specifically co-precipitate PP2A C subunit
(Figure 3A-B). It has been reported that the coiled-coil
domain is the oligomerizati o nd o m a i no ft h es t r i a t i n
Figure 2 The N-terminal region of striatin binds PP2A while Mob3 associates with both N-terminal and more C-terminal striatin
sequences. (A) HEK293 cells transfected with HA-tagged wild-type and mutant striatins were lysed and HA-striatin immune complexes were
isolated, separated by SDS-PAGE, and proteins contained in the immunoprecipitates were detected by immunoblotting using antibodies that
recognize the HA-epitope tag, PP2A C subunit, and Mob3. (B) Relative binding of PP2A C subunit and Mob3 to wild-type striatin and C-terminal
truncation mutants of striatin was determined by quantitatively comparing the C subunit/HA-striatin and Mob3/HA-striatin ratios of wild-type
striatin to those of the mutants using a Bio-Rad Fluor S-Max chemilumimager (see Methods). (C) Immunoblot showing that Mob3 also associates
with residues 310-780 of striatin while PP2A does not. (D) Relative binding of PP2A C subunit and Mob3 to wild-type and Δ(3-309) striatins was
measured in the same manner as described in B. The HA-striatins migrated at different positions due to their size differences but are shown side
by side in panels A and C for comparison of their levels. C subunit can migrate as either singlets or doublets; whether double or single bands
are seen can vary for the same sample from gel to gel. This pattern of migration in SDS-PAGE has been noted previously for endogenous PP2A
C subunits [40-43] and is not due to degradation. The error bars in panels B and D represent the standard deviation of at least three
independent experiments. *, p ≤ 0.05; **, p ≤ 0.01 relative to wild-type.
Gordon et al. BMC Biochemistry 2011, 12:54
http://www.biomedcentral.com/1471-2091/12/54
Page 4 of 18family of proteins [15]. In agreement with this, Δ(70-
116) striatin fails to oligomerize with SG2NA and zine-
din, as demonstrated by the absence of SG2NA and
zinedin in immunoprecipitates of this mutant (Figure
3A-B). Δ(70-116) also shows reduced ability to bind
Mob3, binding only 40% of wild-type levels. Considering
the fact that there is a Mob3 binding domain in aa1-269
of striatin that can bind approximately 55% of the wild-
type level of Mob3 (Figure 2B), these results suggest
that the coiled-coil domain contains binding sites for
both PP2A and Mob3.
In addition to the coiled-coil domain, striatin has been
reported to bind caveolin-1 through a caveolin-binding
domain found within amino acid residues 53-63 [10].
To determine the role, if any, of the caveolin-binding
domain in striatin association with PP2A and Mob3, a
Figure 3 The coiled-coil and caveolin-binding domains are required for oligomerization and PP2A binding but the calmodulin-binding
domain is not. (A) HEK293 cells transfected with HA-tagged wild-type and mutant striatins were lysed and HA-striatin immune complexes were
isolated, separated by SDS-PAGE, and proteins contained in the immunoprecipitates were detected by immunoblotting using antibodies that
recognize the HA-epitope tag, PP2A C subunit, Mob3, SG2NA, and zinedin. Deletion of either the coiled-coil domain [Δ(70-116) striatin] or the
caveolin-binding domain [Δ(53-66) striatin] of striatin resulted in loss of oligomerization and PP2A binding. (B) Relative binding of wild-type and
deletion mutant striatins to PP2A C subunit, Mob3, SG2NA, and zinedin was measured as described in the legend to Figure 2B. (C) A similar
experiment to (A) was conducted with wild-type striatin and Δ(148-166) striatin, which deletes the striatin calmodulin-binding motif. (D) Relative
binding of wild-type and mutant striatins to PP2A C subunit, Mob3, SG2NA, and zinedin was measured as described in the legend to Figure 2B.
The HA-striatins migrated at different positions due to their size differences but are shown side by side in panels A and C for comparison of
their levels. The error bars in panels B and D represent the standard deviation of at least three independent experiments. *, p ≤ 0.05; **, p ≤ 0.01
relative to wild-type.
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Δ(53-66) striatin, was analyzed. Co-immunoprecipitation
studies revealed that Δ(53-66) striatin binds little to no
PP2A (Figure 3A-B). In contrast, the Δ(53-66) striatin
mutant could co-precipitate Mob3 at near wild-type
levels, confirming that loss of PP2A binding is specific
and not due to protein misfolding. Interestingly, this
mutant is completely defective in oligomerization as
indicated by its inability to bind SG2NA and zinedin
(Figure 3A-B), indicating that one or more residues
within 53-66 are essential for striatin oligomerization.
Finally, we examined the importance of the calmodu-
lin-binding domain in the N-terminus of striatin by ana-
lyzing the striatin deletion mutant, Δ(148-166), which
deletes this entire domain (Figure 1). Loss of striatin’s
calmodulin-binding domain has only a small effect on
PP2A C subunit binding, and no significant effect on
Mob3 binding or oligomerization with SG2NA and zine-
din (Figure 3C-D).
Residues in the coiled-coil domain of striatin are critical
for PP2A C subunit association independent from their
role in oligomerization
The fact that the coiled-coil domain of striatin is
required for its association with PP2A suggested that
PP2A might bind directly to this region. If so, the intro-
duction of point mutants in the coiled-coil domain may
disrupt PP2A binding without interfering with striatin
oligomerization. To test this hypothesis, we compared
the peptide sequence of the coiled-coil domain of stria-
tin from several species and identified residues that





101. Pairs of these residues
were substituted with uncharged serine residues or resi-
dues of opposite charge in an attempt to disrupt stria-
tin/PP2A association. The resulting double point
mutants, R88S/K89E and R100S/R101E striatin, were
then analyzed for PP2A, Mob3, and SG2NA binding.
The mutants R88S/K89E and R100S/R101E are able to
bind only 40% and 10% of wild-type levels of PP2A C
subunit, respectively (Figure 4A-B). Binding of Mob3
was not reduced. Both mutants retained the ability to
efficiently bind SG2NA at wild-type (R88S/K89E) or
near wild-type (81%; R100S/R101E) levels (Figure 4A-B),
indicating that effects on PP2A C subunit can be sepa-
rated from effects on oligomerization. These results sup-
port the hypothesis that PP2A binds directly to the
coiled-coil domain of striatin.
To further investigate PP2A binding in the coiled-coil
domain, four conserved hydrophobic residues (leucines
84, 94, and 105, and isoleucine 102) were replaced with
alanine. Two triple mutants (L84A/L94A/I102A and
L84A/L94A/L105A) reduced PP2A binding to 32% to
17% of wild-type levels, while striatin oligomerization
remained intact (Figure 4C-D). No statistically signifi-
cant reduction in the binding of Mob3 was seen.
Together, these results show that critical residues in the
PP2A binding domain of striatin are within the central
portion of the coiled-coil domain between residues 84
and 105.
To define whether the coiled-coil domain was suffi-
cient to bind PP2A and to test the importance of the
amino acids preceding the caveolin-binding domain for
PP2A binding, two additional mutants (P132Stop and
46-131) were constructed (Figure 1). Both of these
mutants contain the coiled-coil domain. Because the
caveolin-binding domain is also required for PP2A bind-
ing (Figure 3) both mutants were designed to retain this
domain as well, but mutant 46-131 lacks most of the
amino acids that precede it. PP2A binds efficiently to
both mutants, demonstrating that the binding site for
PP2A is within striatin amino acids 46-131 and that the
first forty-five amino acids of striatin are dispensable for
PP2A binding (Figure 4E).
Determinants within striatin residues 191-344 are critical
for binding to Mst3 and Mst4 kinases and to CCM3
We next investigated the association of striatin with
Mst3 kinase, a recently discovered component of stria-
tin family complexes [9]. Initial experiments showed
that Mst3 does not bind to Δ(3-309) striatin (Figure
5A), indicating that striatin residues before 310 are cri-
tical for its association. However, Mst3 bound well to
Δ(70-116) striatin (Figure 5A) and Δ(53-66) (data not
shown), indicating that Mst3 association with striatin
does not require the coiled-coil or caveolin-binding
domains or oligomerization of striatin. This result also
indicates that the loss of PP2A binding to Δ(70-116)
seen in Figure 3A-B is not simply due to misfolding of
this mutant.
To further delineate the striatin residues needed for
Mst3 binding, the ability of Mst3 to associate with a set
of deletion mutants spanning regions of unknown func-
tion between the coiled-coil domain and residue 344 of
striatin (Figure 1) was measured. The results of this ana-
lysis (Figure 5B-C) indicate that deletion of the residues
between the coiled-coil domain and the calmodulin
domain and deletions after the calmodulin-binding
domain up to residue 193 cause no reduction in Mst3
binding. However, deletion of residues 191-269 causes a
~33% reduction in Mst3 binding while loss of residues
270-344 causes an ~85% loss of Mst3 binding. Deletion
of striatin amino acids 191-269 and 270-344 also
reduced Mst4 binding by 33 ± 5% and 75 ± 3%, respec-
tively (average ± range of two experiments). These
results indicate that the Mst3 and Mst4 binding sites
probably span across amino acid 269, with the strongest
interactions being C-terminal to this residue.
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lize Mst3 and Mst4 [21], the importance of striatin
residues 191-269 and 270-344 for CCM3 binding was
tested. Since commercially available CCM3 antibodies
did not consistently detect CCM3, we established a
stable FLAG-tagged CCM3-expressing cell line as
described in Methods and analyzed the ability of this
CCM3 to associate with HA-tagged wild-type and
Figure 4 Conserved residues within the coiled-coil domain of striatin are critical for association with PP2A but not with Mob3. (A)
HEK293 cells transfected with HA-tagged wild-type and coiled-coil mutant striatins were lysed and HA-striatin immune complexes were isolated
and proteins contained in the immunoprecipitates were detected by immunoblotting using antibodies that recognize the HA-epitope tag, PP2A
C subunit, Mob3, and SG2NA. (B) Relative binding of wild-type and point mutant striatins to PP2A C subunit, Mob3, and SG2NA was measured
as described in the legend to Figure 2B. The error bars represent the standard deviation of at least three independent experiments. *, p ≤ 0.05;
**, p ≤ 0.01 relative to wild-type. (C) A similar experiment to (A) was conducted with wild-type striatin and striatin mutants with hydrophobic
coiled-coil residue substitutions. (D) Relative binding of wild-type and point mutant striatins to PP2A C subunit, Mob3, and SG2NA was
measured as described in the legend to Figure 2B. The error bars represent the standard deviation of at least three independent experiments. *,
p ≤ 0.05; **, p ≤ 0.01 relative to wild-type. The difference in C subunit association between L84A/L94A/I102A and L84A/L94A/L105A was also
significant (p = 0.029). (E) A similar experiment to (A) was conducted with wild-type striatin and small, coiled-coil-containing mutants, P132Stop
striatin and 46-131 striatin. The HA-striatins migrated at different positions but are shown side by side for comparison of their levels. Although
some non-specific sticking of C subunit was seen in the vector control lane, both mutants bound wild-type levels of PP2A C subunit.
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of striatin residues 191-269 and 270-344 reduced
CCM3 binding ~40% and ~90%, respectively (Figure
6A-B), suggesting that CCM3 and the Mst3 and Mst4
kinases may bind as a complex to this region of
striatin.
The calmodulin-binding domain of striatin negatively
regulates association with the Mst3 and Mst4 kinases
The deletion mutant, Δ(115-149) striatin, had a statis-
tically significant ~25% increase in the amount of Mst3
bound (Figure 5C). Since this region is just before the
calmodulin-binding domain of striatin, we tested the
ability of Mst3 to bind to Δ(148-166) striatin, in which
the calmodulin-binding domain has been deleted. At
the same time, we tested an additional mutant, Δ(227-
309) striatin, spanning the region that seemed to affect
Mst3 binding the most. The results indicate that Δ
(227-309) striatin is almost completely defective in
Mst3 binding, while still binding Mob3 at 75% of wild-
type levels (Figure 7A-B). In striking contrast, Mst3
bound ~3.5-fold better when the calmodulin-binding
domain of striatin was deleted (Figure 7A-B).
Figure 5 Characterization of Mst3 association with striatin. (A)
Three days after transfection with HA-tagged wild-type and mutant
striatins, HEK293 cells were lysed and HA-striatin immune complexes
were isolated, separated by SDS-PAGE, and immunoblotted.
Representative immunoblots are shown. Left, Mst3 binding, like
PP2A C subunit binding, requires N-terminal sequences of striatin.
Right, unlike PP2A C subunit, Mst3 binding does not require the
striatin coiled-coil domain or striatin oligomerization. (B) A similar
experiment to (A) was conducted to compare the abilities of Mst3
and Mob3 to bind wild-type striatin and a set of internal striatin
deletion mutants localized to regions of unknown function. (C)
Relative binding of wild-type and mutant striatins to Mst3 and
Mob3 was measured as described in the legend to Figure 2B. The
error bars represent the standard deviation of at least three
independent experiments. *, p ≤ 0.05; **, p ≤ 0.01 relative to wild-
type.
Figure 6 CCM3 binding to striatin is affected by the same
deletions that reduce Mst3 binding. (A) Three days after
transfection with HA-tagged wild-type and mutant striatins, HEK293
cells stably expressing FLAG-CCM3 were lysed and FLAG-CCM3
immune complexes were isolated, separated by SDS-PAGE, and
immunoblotted. Lysate levels of the transfected HA-tagged striatins
are shown for comparison to the amount of HA-striatins that
coimmunoprecipitated with FLAG-CCM3. (B) Relative binding of
wild-type and mutant striatins to FLAG-CCM3 was measured as
described in the legend to Figure 2B, except that in this experiment
the values were normalized to expression of the HA-constructs in
the cell lysates. The error bars represent the standard deviation of
three independent experiments. **, p ≤ 0.01 relative to wild-type.
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for the related striatin-associated kinase, Mst4,
revealed a less dramatic reduction (38%) in Mst4 bind-
ing to Δ(227-309) striatin but a similar ~4-fold
increase in binding to the calmodulin-binding domain
deletion mutant.
Striatin-associated PP2A negatively regulates the
phosphorylation of Mst3 kinase
Previously, two-dimensional analysis of SG2NA com-
plexes from
32P-inorganic phosphate-labeled cells
revealed an ~52 kDa unknown protein whose phosphor-
ylation increased dramatically upon treatment of cells
with okadaic acid at concentrations known to inhibit
PP2A [14]. The size and estimated isoelectric point of
that phosphoprotein are similar to Mst3, raising the
possibility that striatin-associated PP2A regulates the
phosphorylation state of striatin-associated Mst3. To
test this possibility, we took advantage of the fact that
phosphorylation slows the mobility of many proteins.
Figure 8A shows that upon incubation with ATP and
manganese in vitro, a portion of Mst3 undergoes a gel
shift on SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). The gel shift does not occur in the absence of
ATP or if the kinase inhibitor staurosporine is included
(Figure 8A), indicating that the shift occurs due to
autophosphorylation of Mst3 or phosphorylation of
Mst3 by a tightly associated kinase.
Mst3 in lysates from untreated human 293 cells exists
predominantly as one major band and a minor, more
slowly migrating, upper band (Figure 8B, first lane).
Upon treatment with 100 nM okadaic acid, the Mst3 in
the lower band shifts to the upper band over time until
at 4 h the upper band becomes the predominant band
(Figure 8B). It was previously shown that treatment of
mammalian cells with 100 nM okadaic acid for 6 h-24 h
inhibits most cellular PP2A without significantly inhibit-
ing PP1 because of the slow rate at which okadaic acid
enters cells [31]. Considered together, these results indi-
cate that Mst3 phosphorylation may be regulated by
PP2A.
Okadaic acid-induced phosphorylation of Mst3 could
be due to inhibition of PP2A in the striatin complex or
to inhibition of another PP2A holoenzyme responsible
for regulating the phosphorylation state of Mst3. To dis-
tinguish between these two possibilities, we tested
whether selectively reducing the amount of PP2A asso-
ciated with striatin would increase the steady-state phos-
phorylation level of Mst3 in those striatin complexes.
We reasoned that if PP2A in the striatin complex were
responsible for dephosphorylation of striatin-associated
Mst3, then mutant striatins with reduced PP2A binding
would bind phosphorylated Mst3 but dephosphorylate it
at a reduced rate, causing the accumulation of hyper-
phosphorylated Mst3 in those striatin complexes.
To test this prediction, the four PP2A-deficient stria-
tin coiled-coil domain point mutants were used. In
cells expressing these mutants, PP2A that is not com-
plexed with striatin (~98% of PP2A in the cell [8]) will
be unaffected; only the amount of PP2A associated
Figure 7 Loss of striatin residues 227-309 nearly abolishes
Mst3 binding while loss of the calmodulin domain greatly
enhances the binding of both Mst3 and Mst4. (A) Three days
after transfection with HA-tagged wild-type and mutant striatins,
HEK293 cells were lysed and HA-striatin immune complexes were
isolated, separated by SDS-PAGE, and immunoblotted. The Mob3
panel shown has been compressed 25% in the vertical dimension
to save space. (B) Relative binding of wild-type and mutant
striatins to Mst3, Mst4, and Mob3 was measured as described in
the legend to Figure 2B. The error bars represent the standard
error of four independent experiments. *, p ≤ 0.05; **, p ≤ 0.01
relative to wild-type.
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ratio of the upper (hyperphosphorylated) and lower
bands of Mst3 associated with the PP2A-deficient
striatin mutants with the ratio of these Mst3 bands
associated with wild-type striatin. Figure 8C (HA-IP)
shows the results of a representative experiment. Mst3
associated with striatin mutants deficient in binding
PP2A has a greater proportion of the upper band than
Mst3 associated with wild-type striatin, indicating that
there is an increased amount of hyperphosphorylated
Mst3 associated with the PP2A-deficient striatin
mutants. Quantitative analysis of several experiments
showed that Mst3 hyperphosphorylation was signifi-
cantly increased in all four of our PP2A-deficient stria-
tin complexes (Figure 8D; black columns), with the
greatest increase in the R100S/R101E mutant shown in
F i g u r e4t ob et h em o s td e f e c t i v ei nb i n d i n gP P 2 A .
The reduction of PP2A binding to striatin causes the
hyperphosphorylation (gel shift) of a large fraction of
the associated Mst3, as can be seen most clearly by
visual comparison of the Mst3 bands in the wild-type
and R100S/R101E lanes in the HA-IP panel of Figure
8C. More than half of Mst3 associated with the R100S/
R101E mutant is in the upper band.
To determine the effect on the total Mst3 population
in the cell, we also analyzed the amount of hyperpho-
sphorylation (upper band) of Mst3 in lysates from cells
expressing exogenous wild-type or PP2A-deficient
mutant striatins. Figure 8C-D (lysate panel and white
columns) show that expression of PP2A-deficient stria-
tin does cause an increase in total hyperphosphorylated
Mst3 in cells. The most robust increase, ~2.5-fold, was
again induced by expression of the striatin mutant most
deficient in binding PP2A, R100S/R101E.
To definitively prove that the gel shift in Mst3
observed with PP2A-deficient striatin mutants is due to
increased phosphorylation and not some other modifica-
tion, we tested whether gel-shifted Mst3 associated with
R100S/R101E striatin could be eliminated by treatment
with purified PP2A. The slower migrating form of Mst3
disappeared when denatured R100S/R101E striatin
immunoprecipitates were incubated with purified PP2A
but not when they were incubated with PP2A and oka-
daic acid (Figure 8E). Together, these results indicate
Figure 8 Loss of PP2A binding to striatin causes Mst3
hyperphosphorylation. (A) FLAG-Mst3 (FL-Mst3)
immunoprecipitates were prepared, and then aliquots were
incubated without ATP, with ATP, or with ATP plus the kinase
inhibitor, staurosporine. FLAG-Mst3 was visualized by
immunoblotting. (B) Mst3 hyperphosphorylation caused by
incubation of HEK293 cells with 100 nM okadaic acid for the times
indicated retards the migration of Mst3 in SDS-PAGE. U, untreated.
Vehicle Control, DMSO. (C) Three days after transfection of HEK293
cells with HA-tagged wild-type striatin and striatin mutants deficient
in PP2A binding, HA-striatin immune complexes (HA-IP) and lysates
were prepared and immunoblotted. (D) Relative
hyperphosphorylation of Mst3 in striatin complexes and lysates of
transfected cells was quantitated by measuring the ratios of the
upper and lower bands of Mst3 using a chemilumimager and
normalizing to wild-type HA-striatin. The error bars represent the
standard error of at least four independent experiments. *, p ≤ 0.05;
**, p ≤ 0.01 relative to wild-type. The p values for R88S/K89E and
84A/94A/105A mutant effects in lysates were 0.19 and 0.06,
respectively. (E) Three days after transfection of HEK293 cells with
HA-tagged R100S/R101E striatin, HA-striatin immune complexes
were prepared in the absence of phosphatase inhibitors, denatured,
and divided into three equal portions. Samples were incubated
without PP2A or with purified PP2A plus either DMSO (vehicle
control) or 100 nM okadaic acid. After incubation, the Mst3 protein
bands were detected by immunoblotting. All lanes are from the
same gel and exposure but the first two lanes were originally
separated by a blank lane.
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phorylation state of striatin-bound Mst3.
PP2A negatively regulates the activation of striatin-
associated Mst3 kinase
To gain insight into the functional significance of the
PP2A-regulated phosphorylation of Mst3 in the striatin
complex, we determined the sites of phosphorylation on
Mst3 necessary for the observed gel shift. To do this,
the three reported activation loop phosphorylation sites
of Mst3, threonine residues 172, 178, and 182 in Mst3
isoform b (PhosphoSitePlus [32]), were individually
mutated to alanine to prevent their phosphorylation.
After transfection of constructs expressing FLAG-tagged
wild-type and mutant Mst3 isoform b proteins into
HEK293 cells and treatment of the cells with okadaic
acid or vehicle control (DMSO), lysates were analyzed
by immunoblotting with anti-FLAG antibody (Figure 9;
compare top two panels). The results show that muta-
tion of threonine 172 causes a small reduction in the
ratio of shifted to unshifted Mst3 bands while mutation
of either threonine 178 or 182 to alanine abolishes the
okadaic-acid induced gel shift of Mst3.
Next an autophosphorylation site-specific (pT178) anti-
body was used to further analyze the T172A, T178A, and
T182A Mst3 mutants. Because Mst3, Mst4, and STK25
have similar sequences in their activation loops, this anti-
body reacts with all of these kinases when activated by
autophosphorylation. To specifically examine Mst3, lysates
of okadaic acid-treated cells expressing the FLAG-tagged
Mst3 isoform b proteins were first denatured to disrupt
complexes by heating with SDS and reducing agent as
described in Methods. Then anti-FLAG immunoprecipi-
tates of wild-type and mutant Mst3 proteins were pre-
pared and immunoblotted with anti-phospho-Mst3
(pT178) antibody and with anti-FLAG antibody (Figure 9;
two middle panels). The results confirm the specificity of
the anti-phospho-Mst3 (pT178) antibody since only IgG
background is seen in the T178A pMst3 immunoblot lane
while a strong band of the T178A mutant protein is seen
in the FLAG-Mst3 (FL-Mst3) immunoblot panel. The
results also reveal that the T182A Mst3 mutant is phos-
phorylated robustly on threonine 178 and that Mst3 phos-
phorylated on threonine 178 is present in both the lower
and upper bands of the Mst3 doublet in the wild-type and
T172A lanes. Thus, phosphorylation of threonine 178 is
not sufficient to generate the upper Mst3 band, but
appears to be a prerequisite for its formation. No threo-
nine 178 phosphorylation was detected on any of the
FLAG-tagged Mst3 proteins when FLAG-Mst3 immuno-
precipitates were prepared from vehicle control (DMSO)-
treated cells (Figure 9; bottom two panels), indicating that
the Mst3 autophosphorylation on threonine 178 seen with
okadaic acid-treated cells was induced by okadaic acid and
not pre-existing. Together, the results in this section show
that both the upper and lower Mst3 bands contain phos-
phorylated Mst3 species but generation of the upper,
hyperphosphorylated band appears to require at a mini-
mum phosphorylation of both threonine 178 and threo-
nine 182 in the activation loop of Mst3. Thus, the gel shift
seen with PP2A-deficient striatin mutants is indicative of,
but probably an underestimate of, activation and autopho-
sphorylation of Mst3.
Discussion
The results of this study help define the architecture
and regulation of the striatin family complexes. A model
Figure 9 Mutation of either threonine 178 or threonine 182 to
alanine in the activation loop of Mst3 prevents the
hyperphosphorylation-induced gel shift induced by okadaic
acid (OA) treatment. Three days after transfection with empty
vector or FLAG epitope-tagged wild-type (WT) or mutant Mst3
isoform b-expressing plasmids, HEK293 cells were treated with
either DMSO or OA (100 nM) for four hours and then lysed. Lysates
were denatured as described in Methods and FLAG-Mst3 was
immunoprecipitated with anti-FLAG antibody. Cell lysates (Lysates)
and FLAG-Mst3 immunoprecipitates (FLAG IP) were separated by
SDS-PAGE and immunoblotted with anti-FLAG antibody (FL-Mst3)
and phospho-specific antibody recognizing the threonine 178
autophosphorylation site of Mst3 (pMst3). The small arrows denote
the position of IgG heavy chain in the immunoprecipitates. In anti-
FLAG immunoblots of lysates from DMSO-treated cells (top panel), a
background band is seen at the expected position of
hyperphosphorylated Mst3 in all lanes. The fact that this band is
present in the vector control lysate lane and absent in anti-FLAG
Mst3 immunoprecipitates prepared from these lysates (bottom
panel) shows that this band is not Mst3. Okadaic acid induces the
presence of the upper band of FLAG-tagged Mst3 in wild-type (WT)
and T172A Mst3-expressing cells (clearly darker than the vector
control background band), but not in T178A and T182A Mst3-
expressing cells (second panel from the top).
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in Figure 10. The creation of striatin point mutants defi-
cient in PP2A association facilitated a set of experiments
clearly identifying striatin-associated PP2A as the phos-
phatase negatively regulating Mst3 activation in striatin
family complexes. Moreover, mutational analysis of
Mst3 autophosphorylation sites and studies with the
PP2A inhibitor, okadaic acid, provided new insight on
Mst3 activation.
The A and C subunits of PP2A were previously shown
to bind to striatin family complexes but the region of
striatin to which the A/C heterodimer bound was
unknown [8]. Our current data show that the coiled-coil
domain of striatin mediates the formation of this PP2A
heterotrimer (Figure 10). Although we cannot rule out a
direct contribution of the caveolin-binding motif, the
fact that double or triple point mutations in the middle
of the coiled-coil/oligomerization domain of striatin
almost completely disrupt PP2A association suggests
that the primary determinants for PP2A binding are
near the middle of the coiled-coil domain (residues 84-
105).
Our data also suggest that PP2A association with
striatin is dependent on oligomerization of striatin com-
plexes. Of the charged coiled-coil residues that were
mutated to disrupt PP2A binding to striatin, only argi-
nine 88 is predicted to be at the dimerization interface
when either NCOILS [33] or Paircoil2 [34] prediction
programs are used, while the other residues are pre-
dicted to be more available to potentially interact with
PP2A. However, arginine 101, mutated in the R100S/
R101E mutant, is part of a signature in striatin called a
trimerization motif [35], and could have an effect on
topology as well. Of the hydrophobic coiled-coil
mutations, leucine 84, isoleucine 102, and leucine 105
are predicted to be at the dimerization interface, while
leucine 94 may be more accessible. Thus, it is interest-
ing that the striatin mutant L84A/L94A/L105A is signif-
icantly more defective in PP2A binding than the mutant
L84A/L94A/I102A (p = 0.029), because the only differ-
ence between these two mutants is in amino acids pre-
dicted to be at the interface of the helices. These results
are consistent with the idea that association of the PP2A
A/C heterodimer is sensitive to local alterations in the
dimerization interface of striatin. We hypothesize that
this sensitivity results from PP2A binding asymmetri-
cally across the dimerization interface to more than one
striatin family coiled-coil domain. Further support for
this model comes from the fact that deletion of the
caveolin-binding motif, which leaves the residues
mutated above intact, abolishes oligomerization of stria-
tin and its association with PP2A. Thus, although a pre-
cise understanding of the effects of the different striatin
mutants on PP2A association may await crystallization
studies, our current data are consistent with a model in
which the PP2A A/C heterodimer binds to the coiled-
coil domain of striatin family members in an oligomeri-
zation-dependent manner. Because we have shown that
Mst3 binding to striatin is not dependent on striatin
family oligomerization, this model provides an attractive
feature of restricting the regulation of striatin-associated
Mst3 by PP2A until oligomerization occurs.
A surprising result from this study was the complete
loss of oligomerization caused by deletion of the caveo-
lin-binding motif within striatin (mutant Δ(53-66)). A
previous study [15] reported that a fusion protein con-
sisting of residues 81-131 of mouse SG2NA (corre-
sponding to striatin amino acids 65-115) fused to the C-
Figure 10 Model of human wild-type striatin complex, based on results from previous studies and the current study.S c h e m a t i co f
wild-type human striatin, drawn to scale, showing the locations of its previously published protein-interaction motifs/domains and residues or
domains determined in this study to be important for binding of the striatin-associated proteins. Previously published domains: Caveolin (Cav)-
binding motif (aa53-63); C-C, coiled-coil region (aa70-116); Calmodulin (CaM)-binding domain (aa149-166); WD-repeat domain (aa419-780). The
Cav-binding motif and CaM-binding domain are indicated by arrows with corresponding proteins below. Estrogen receptor alpha (not shown)
has been found to bind to striatin amino acids 1-203 [23]. Upper labels (from this study): Names are as indicated. Residues important for the
binding of these proteins are indicated by arrows or by brackets. Mst4 binding was not affected as dramatically as Mst3 by Δ(227-309) so it may
have an overlapping, but not identical, binding site. Note: The amino acid stretch in striatin important for Mst3/CCM3 association contains a
small region of amino acid homology with PP2A B’ B-type subunits that we previously identified [8]. Whether these residues play a role in
binding Mst3/CCM3 remains to be tested.
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sons. One possible explanation for both of these results
is that striatin family oligomerization requires binding of
caveolin. This would have to be a transient requirement,
however, because we could find no associated caveolin
even in wild-type striatin immunoprecipitates (data not
shown) and no caveolin was found in striatin family
complexes in a recent proteomics study [9]. Alterna-
tively, loss of oligomerization could result from one or
more of the deleted residues being directly required for
oligomerization. Analyses using NCOILS [33] and Pair-
coil2 [34] prediction programs suggest that the N- and
C-terminal limits previously assigned to the coiled-coil
domain of striatin (70-116; [11]) may need to be
extended. Using a 21 residue window with NCOILS,
which is recommended for locating the ends of coil-
coils, and an unweighted analysis (heptad residues a-g
given equal weight), probabilities of almost 1 are
obtained for residues 61-69 being part of the coiled-coil
of human striatin. Weighted analysis (residues a and d
given 2.5-fold more weight than the other heptad resi-
dues) using the same window still assigns these residues
high probability (0.621 for residues 61-63 and 0.956 for
residues 64-69) of being part of the coiled-coil. Results
from similar analyses of human SG2NA suggest that
SG2NA residues corresponding to striatin aa61-69
(unweighted) or aa64-69 (weighted) have a high prob-
ability of being part of the coiled-coil. Finally, for
human zinedin, NCOILS predicts unweighted and
weighted N-terminal ends corresponding to striatin aa56
and aa61, respectively. For striatin, SG2NA, and zinedin,
these analyses also suggest that the C-terminal end of
the coiled-coil may be around aa120-121. Paircoil2 ana-
lysis of these proteins predicts a similar end to the
coiled-coil but an even earlier start to it, ranging from
striatin aa56-61, potentially including much of the
caveolin-binding motif, residues 53-63. The results of
these analyses are consistent with the idea that our
caveolin deletion mutant and the GFP-SG2NA fusion
protein published by others may have removed amino
acids critical to the formation of striatin coiled-coils.
Since the missing residues common to both of these
constructs are residues 53-64, it is possible that these
are the critical amino acids. In fact, the complete loss of
coiled-coil formation caused by our small caveolin-bind-
ing motif deletion is reminiscent of “trigger” sequences,
sequences absolutely required for coiled-coil formation
[36]. Additional analyses will be needed to firmly define
the striatin coiled-coil and resolve these possibilities.
There are at least two distinct domains within striatin
( a a 1 - 2 6 9a n da a 3 1 0 - 7 8 0 )t h a ti n t e r a c td i r e c t l yo ri n d i r -
ectly with Mob (Figure 10). The C-terminal striatin resi-
dues important for Mob3 binding were further
narrowed down by the fact that deletion of striatin
residues 270-344 had no significant effect on Mob3
binding (Figure 5C). This result suggested that the most
important C-terminal determinants of striatin for Mob
binding likely occur after residue 344 and include the
WD domain. However, because of the larger standard
deviation of Mob3 binding to the Δ(270-344) mutant, a
contribution of striatin residues 310-344 cannot be com-
pletely ruled out. In the N-terminus of striatin, Mob3
binding seems to be largely restricted to the coiled-coil
domain because deletion mutants collectively spanning
residues 115-269 and a mutant deleting the caveolin-
binding motif had no significant effect on Mob3 bind-
ing, while deletion of the coiled-coil domain had the
same reduction of Mob3 binding as the Δ(3-309) striatin
mutant. The fact that Mob3 binds much better to the
caveolin-binding motif deletion mutant than to the
coiled-coil deletion mutant and close to wild-type levels
also supports the idea that Mob3 binding to the striatin
N-terminus is not highly dependent on oligomerization.
This result suggests that Mob3 binding to the striatin
N-terminus is not solely due to indirect binding of
Mob3 through oligomerization of endogenous striatin
family members with mutants. However, additional stu-
dies are necessary to strengthen this conclusion. It has
not been firmly established whether Mob3 binds directly
or indirectly to striatin. A previous study identified
Mob3 (phocein) by its binding to striatin in a two-
hybrid assay but no additional data was presented to
rule out the possibility that the interaction was mediated
by a conserved protein in yeast (e.g., PP2A A and C
subunits) bridging the association. Mob3 binds striatin
independently of PP2A C subunit, Mst3, and CCM3
because when close to 85% of the latter associations
were disrupted by various mutations little to no reduc-
tion in Mob3 binding was seen. Since PP2A C subunit,
Mst3, and CCM3 are other core striatin binding part-
ners, the results support the model that Mob3 binds
directly to striatin. However, the question of whether
striatin binds two molecules of Mob3 or uses two bind-
ing domains to interact with a single molecule of Mob3
still needs to be resolved. Given our other data on the
organization of the striatin complex, it is tempting to
speculate that binding of two striatin domains to one
Mob3 molecule might function in part to bring Mst3
and PP2A into proximity in the 3D structure of striatin.
The results of this study show that striatin-associated
PP2A is the phosphatase responsible for negatively regu-
lating the phosphorylation and activation of Mst3 in
striatin family complexes. Four separate striatin point
mutants deficient in PP2A binding showed hyperpho-
sphorylation of associated Mst3. Moreover, hyperpho-
sphorylated, gel-shifted Mst3 could also be detected in
lysates from cells expressing these mutants, indicating
that these mutants cause the hyperphosphorylation of a
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activation loop point mutants, autophosphorylation site
T178-specific antibody, and okadaic acid to inhibit
PP2A and activate Mst3 in vivo [37], we demonstrated
that gel-shifted Mst3 was indicative of Mst3 activation
and autophosphorylation in vivo. This conclusion is
further supported by previous studies that reported a gel
shift of Mst3 upon autophosphorylation in vitro [19,38],
and a consequential increase in kinase activity after
autophosphorylation [38]. Our data further show that
the Mst3 gel shift represents an underestimation of the
amount of Mst3 autophosphorylated on threonine 178,
the reported site of Mst3 autophosphorylation for
Mst3b [19], because phosphorylation at both threonines
178 and 182 on Mst3b appears to be required to obtain
the observed gel shift. Thus, striatin-associated PP2A
negatively regulates the phosphorylation and activation
of Mst3, and likely of the other related kinases in stria-
tin family complexes, Mst4 (which is also gel-shifted
upon okadaic acid treatment) and STK25, as well. The
fact that reduction in striatin-associated PP2A is suffi-
cient to cause activation of Mst3 suggests that one way
the Mst3 and the other GCKIII kinases could be regu-
lated is by modulation of striatin-associated PP2A activ-
ity or modulation of PP2A’s access to Mst3 in striatin
family complexes. An important goal of future research
on these complexes will be to determine if these
mechanisms exist, and if so, to elucidate them.
Previous data suggested that threonine 182 was not a
major autophosphorylation site on Mst3 [19]. However,
this data was largely based on peptide phosphorylation
studies. We (Figure 8A) and others [19,38] have found
that incubation of immunoprecipitated Mst3 in the pre-
sence of ATP and manganese generates the hypershifted
form of Mst3 in vitro. Considered together with the cur-
rent result that mutation of threonine 182 to alanine
completely prevents the gel-shift of Mst3 without block-
ing the phosphorylation of threonine 178, this finding
supports the notion that threonine 182 is a major autop-
hosphorylation site of Mst3. The fact that there is no
detectable gel shift when either threonine 178 or threo-
nine 182 is mutated to alanine is intriguing. One possible
explanation is that simultaneous phosphorylation at both
of these sites is required to produce the gel shift. Another
possibility is that there may be a preference for sequential
phosphorylation of Mst3 activation loop phosphorylation
sites, with phosphorylation at threonine 178 being a pre-
requisite for phosphorylation at threonine 182, which in
turn is required for the observed gel shift to occur. Evi-
dence for an interdependence in activation loop phos-
phorylations has been noted previously for other kinases
such as Chk2 [39]. Availability of a phospho-specific anti-
body for threonine 182 of Mst3 would be helpful for dis-
tinguishing between these and other possibilities.
Deletion of the calmodulin-binding domain (Δ(148-
166) striatin), which has no effect on striatin oligomeri-
zation or binding of Mob3 to striatin and little effect on
PP2A association with striatin (Figure 3C-D), caused a
3- to 4-fold increase in both Mst3 and Mst4 association
with striatin. This result is consistent with the possibility
that the calmodulin-binding domain negatively regulates
the binding of Mst3 and Mst4 in striatin family com-
plexes. The effect of this deletion mutant is not simply
due to the removal of amino acids in this general area
of the striatin sequence because adjacent deletions on
either side of the calmodulin-binding domain had either
no effect or only a modest 25% increase in Mst3 bind-
ing. Given that we and others have shown that striatin
family members associate with calmodulin in a calcium-
dependent manner [8,11,12], calcium may regulate Mst3
and Mst4 recruitment to striatin complexes by regulat-
ing calmodulin binding to striatin. However, it is also
possible that removal of these specific sequences modi-
fies Mst3 binding in a manner that will not be recapitu-
lated by changes in calcium. Further experimentation
will be required to distinguish between these
possibilities.
Conclusions
The results of this study help define the architecture of
striatin complexes by identifying residues of striatin
important for complex formation with Mob3, PP2A,
Mst3, Mst4, and CCM3. Our data support the novel
hypothesis that PP2A binding to the coiled-coil domain
requires striatin family oligomerization, which has impli-
cations for the assembly of striatin family complexes
and the ability of PP2A to regulate other components of
these complexes. The finding of residues critical for
striatin oligomerization N-terminal to its previously
assigned coiled-coil domain combined with results from
analyses using coiled-coil prediction programs suggest
that striatin’s coiled-coil domain may begin earlier in
the striatin sequence than previously thought. In addi-
tion, our results support a model in which striatin binds
Mst3 and CCM3 likely as a dimer via residues lying
between striatin’s calmodulin-binding and WD-domains
and recruits the PP2A A/C heterodimer to its coiled-
coil/oligomerization domain to regulate Mst3. Striatin-
associated PP2A is critical for efficient dephosphoryla-
tion and inactivation of striatin-associated Mst3. Upon
inhibition of PP2A by okadaic acid, Mst3 activation
appears to involve autophosphorylation of its activation
loop phosphorylation sites, resulting in a gel shift on
SDS-PAGE. Mob3 can associate with striatin sequences
C-terminal to the Mst3 binding site but also with
sequences proximal to striatin-associated PP2A, consis-
t e n tw i t hap o s s i b l er o l ef o rM o b3i nt h er e g u l a t i o no f
Mst3 by PP2A.
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Antibodies
Anti- HA-tag antibodies, 12CA5 and F7 (available from
Santa Cruz Biotechnology) were used for immunopreci-
pitation of HA-tagged proteins, while anti-HA antibody
16b12 (Covance) was used for immunoblotting. Other
antibodies used include mouse monoclonal anti-FLAG
epitope tag antibody M2 (Sigma), PP2A C subunit anti-
body (BD Transduction Labs), anti-SG2NA mouse
monoclonal antibody S68 [14] (available from Millipore
and Santa Cruz Biotechnology or by request to the cor-
responding author), anti-Mob3 rabbit polyclonal anti-
body RK130 [14], and rabbit monoclonal antibodies
anti-Mst3, anti-Mst4, and anti-Mst4(pT178)/Mst3
(pT190)/STK25 (pT174) (Epitomics, Inc.). Mst3 has two
isoforms, a longer isoform, referred to as isoform a, and
a shorter isoform, isoform b. The anti-phospho Mst4/
Mst3/STK25 antibody mentioned above detects Mst3
isoform a that is phosphorylated on threonine 190 in its
activation loop or Mst3 isoform b phosphorylated on its
corresponding activation loop threonine, threonine 178.
Because we used FLAG epitope-tagged Mst3 isoform b
for experiments utilizing this antibody, we have referred
to this antibody as anti-Mst3 (pT178) in this report.
Plasmids, mutagenesis, and creation of stable cell lines
A human striatin cDNA clone was assembled from ESTs
by standard approaches, sequenced in its entirety to con-
firm that it contained no mutations, and inserted into
pEGFP-N3 with a modified multiple cloning site to make
pEGFP-N3-wild-type striatin. Standard restriction clon-
ing and PCR mutagenesis techniques were then used to
make point mutations or small deletions in pEGFP-N3-
wild-type striatin, except that in most cases PCR was car-
ried out using Herculase
® II polymerase (Stratagene)
because this enzyme was necessary for efficient PCR of
GC-rich striatin sequences. The striatin deletion mutants
containing only the coiled-coil domain or coiled-coil and
caveolin-binding domains were made by standard cloning
procedures in a modified lentivirus plasmid (pLenti6/V5-
D-Topo; Invitrogen) with an N-terminal double HA epi-
tope tag, but were used as plasmids (i.e., transfected).
The empty vector and wild-type striatin expressed in the
same construct as the mutants were used as controls. All
striatin mutants were sequenced.
The cDNA of human Mst3 isoform b (Mst3b; Clone
ID HsCD00042929) was obtained from the Dana-Far-
ber/Harvard Cancer Center DNA Resource Core. The
hMst3b ORF was PCR-amplified and ligated into Hin-
dIII-EcoRI sites of pcDNA3.1 with a HindIII-HindIII N-
terminal FLAG epitope tag, excised with the tag by cut-
ting with NheI and ApaI, and ligated into an XbaI-ApaI
digested backbone from the plasmid pLenti6/V5-D-
Topo. Standard PCR mutagenesis procedures were used
to introduce the threonine to alanine point mutations in
the activation loop. The cDNA of human CCM3 (Cata-
log No. SC320246) was obtained from OriGene Tech-
nologies, Inc. and the hCCM3 ORF was PCR-amplified
and inserted into a modified pLenti6/V5-D-Topo plas-
mid with an N-terminal FLAG epitope tag. To create
HEK293 cells stably expressing FLAG-tagged hCCM3,
cells were infected with lentiviruses that express either
empty lentivirus plasmid with a FLAG epitope or lenti-
virus plasmid expressing N-terminally FLAG-tagged
hCCM3. Infected cells were incubated in media supple-
mented with 7 ug/ml of blasticidin to select cells that
stably express FLAG-tagged CCM3. The selected stable
cell lines were used to perform co-immunoprecipitation
experiments after transfecting with a set of striatin dele-
tion mutants and controls.
Cell culture, transfections, and cell lysis
HEK293 cells were cultured in Dulbecco’sm o d i f i e d
Eagle’s medium supplemented with 5 or 10% fetal calf
s e r u ma t3 7 ° Ci n1 0 %C O 2. For experiments, HEK293
cells were plated into 60 mm dishes at 15% confluence
and grown at 37°C for 16-24 hours. The cells were then
transfected using FuGENE™ 6t r a n s f e c t i o nr e a g e n t
(Roche Diagnostics) according to the manufacturer’s
protocol. Control inclusion of a small amount (one-
tenth of other DNAs) of GFP expressing plasmid in
some experiments showed > 50% of cells were routinely
being transfected. After a minimum of 48 h to allow the
wild-type and mutant striatins to express and bind asso-
ciated proteins in the cells, the cells were washed with
ice cold phosphate-buffered saline and then with IP
wash buffer (0.135 M NaCl, 10% glycerol, 20 mM Tris,
pH 8.0) prior to being lysed with IP lysis buffer (IP
wash buffer containing 1% Nonidet P-40, 1 mM phenyl-
methylsufonyl fluoride, 0.04 trypsin inhibitor units/ml
aprotinin, and in the case of phosphorylation-related
experiments, 50 mM sodium fluoride and 100 nM oka-
daic acid (LC Laboratories) to prevent dephosphoryla-
tion in lysates) by rocking for 20 minutes at 4°C. Lysates
were cleared by centrifugation at 13,000 × g.
Immunoprecipitation, gel electrophoresis, and
immunoblotting
To immunoprecipitate HA-tagged proteins and com-
plexes, cleared lysates were incubated with 12CA5 anti-
HA antibody and protein A-Sepharose 4B beads (Invi-
trogen) or F7 anti-HA-agarose conjugate (when probing
for Mst3, Mst4, or pMst3; Santa Cruz Biotechnology #
sc-7392 AC) for 1.5 hours at 4°C with rocking. FLAG
epitope-tag immunoprecipitates were prepared in the
same manner with M2 anti-FLAG antibody (Sigma-
Aldrich) and recombinant protein G-Sepharose 4B
beads (Invitrogen). Immune complexes were harvested
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saline, twice in IP lysis buffer, and heated at near boiling
in sample buffer for 5 minutes. Immune complexes were
resolved by SDS-PAGE. Proteins were transferred to
nitrocellulose for immunoblotting. Clean Blot (Pierce;
1:1000) was used for detection of Mst3, Mst4, or pMst3
in most cases to reduce background from the immuno-
precipitating IgG heavy chain. Bands from immunoblot-
ting were visualized by enhanced chemiluminescence
and a Fluor S-Max Chemilumimager (Bio-Rad). The
chemilumimager directly measures band intensities
without the use of film via a supercooled CCD camera
that provides linear data over 4.8 orders of magnitude.
This method yields highly reproducible results that do
not vary with image capture times. For mapping experi-
ments in which the amount of associated proteins were
being compared, only experiments in which similar
expression of wild-type and mutants were obtained were
used for quantitation to avoid an artificial bias from dif-
ferent levels of expression. Quantitation of striatin levels
in vector control cells and HA-wild-type striatin trans-
fected cells indicates that 1 ug striatin transfected into a
60 mm dish of cells results in close to a 1:1 level of
expression of HA-wild-type striatin to endogenous stria-
tin (data not shown). The amount of DNA used for
experiments in this study ranged from 0.5-2 ug.
Phosphorylation of Mst3 in vitro
Three days after transfection of HEK293 cells with a
plasmid encoding FLAG-tagged wild-type Mst3, FLAG
immunoprecipitates were prepared and washed twice
with phosphate buffered saline (pH 7.3), twice with lysis
buffer, and once with tris buffered saline. The immune
complexes were combined, divided equally into three
tubes, and then suspended in a buffer containing 40
mM 1,4 Piperazine-diethanesulfonic acid (pH7.0) and 2
mM MnCl2. Two samples were incubated with DMSO
(vehicle control) while the other sample was incubated
with 1 μM staurosporine, all for 30 min at room tem-
perature. Then ATP was added to a final concentration
of 20 μM to one vehicle control aliquot and to the
staurosporine-containing aliquot. After incubation for
30 min at room temperature all three reactions were
analyzed by SDS-PAGE and Mst3 protein bands
detected by immunoblotting.
Dephosphorylation of Mst3 in vitro
Three days after transfection with HA-tagged R100S/
R101E striatin, HEK293 cells were lysed in the absence
of phosphatase inhibitors and HA-striatin immune com-
plexes were prepared. The immune complexes were
denatured by heating at near boiling for 5 minutes in
lysis buffer containing 0.5% SDS and 5 mM b-mercap-
toethanol, centrifuged to remove the protein A
sepharose beads, and then the supernatant was divided
into three equal portions. Each sample was then diluted
with a four-fold excess of lysis buffer to capture excess
SDS into mixed micelles with Nonidet P-40. For two of
the samples, the lysis buffer contained purified PP2A
(Millipore) plus DMSO (vehicle control) or 100 nM
okadaic acid. After incubation for 60 minutes at 30°C,
the samples were analyzed by SDS-PAGE and Mst3 pro-
tein bands were detected by immunoblotting.
Immunoprecipitation of denatured lysates
To denature lysates prior to immunoprecipitation, cells
were first lysed in lysis buffer as described above and
then, after clearing the lysates, SDS and b-mercap-
toethanol were added to final concentrations of 0.5%
and 5 mM, respectively. The lysates were then heated at
near boiling for 5 minutes, diluted 1:4 with IP lysis buf-
fer to capture excess SDS into mixed micelles, and then
immunoprecipitated as described above.
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